๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Concord Biotech Limited (NSE:CONCORDBIO)
India flag India ยท Delayed Price ยท Currency is INR
556.30
-4.70 (-0.84%)
Nov 19, 2026, 3:30 PM IST

Concord Biotech Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
11,70410,54912,00110,1698,5327,129
Revenue Growth
4.02%-12.10%18.01%19.20%19.67%15.56%
Gross Profit
7,4506,7667,6846,6726,6115,410
Operating Income
3,4093,0434,6283,8682,9992,290
Net Income
2,8242,6093,7163,0812,4011,749
Earnings Per Share
13.4312.4717.7614.7311.478.36
EPS Growth
-13.03%-29.80%20.62%28.33%37.25%-25.52%

Revenue by Geography

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '25 Mar '24 Mar '23 Mar '22
India
5,6366,6185,3424,3213,392
America
1,0801,3801,0801,4731,315
Others
3,8334,0033,7472,7382,423
Total
10,54912,00110,1698,5327,129

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
4,4584,3193,3542,8171,7101,614
Total Debt
17.523.1629.6997.38315.46624.93
Net Cash (Debt)
4,4404,2963,3252,7191,395988.98
Net Cash Growth
34.65%29.20%22.26%94.98%41.02%-11.58%
Net Cash Per Share
21.1220.5315.8913.006.674.73

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
2,8402,6692,4452,6552,4602,081
Capital Expenditures
-1,016-951.51-1,112-856.89-1,451-1,555
Free Cash Flow
1,8241,7171,3331,7981,009526.36
Free Cash Flow Growth
40.64%28.79%-25.83%78.14%91.72%-

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
63.65%64.14%64.03%65.61%77.49%75.89%
Operating Margin
29.12%28.85%38.57%38.03%35.15%32.12%
Pretax Margin
31.96%32.67%41.21%40.57%37.74%33.32%
Profit Margin
24.13%24.73%30.97%30.30%28.14%24.54%
FCF Margin
15.58%16.28%11.11%17.68%11.83%7.38%

Dividends

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
3.7753.7755.3504.3753.4152.560
Dividend Per Share Growth
0%-29.44%22.29%28.11%33.40%-24.05%
Dividend Yield
0.68%0.74%0.64%0.57%--

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
41.4140.8447.3151.64--
Forward PE
30.4526.2641.5543.46--
P/FCF Ratio
63.8262.04131.8588.50--
PS Ratio
9.9410.1014.6515.65--